Norah G. Verbout

MedicineEnvironmental ScienceImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 6 papers. Top paper: “The protein C activator AB002 rapidly interrupts thrombus development in baboons”.

The protein C activator AB002 rapidly interrupts thrombus development in baboons

Blood(2020)10.1182/blood.2019002771

N/A

0.431DataRank · unranked

11 citations

Norah G. Verbout, Brandon D. Markway, Michael Wallisch, Christina U. Lorentz, Monica T. Hinds +7 more

Thrombin generation and activity in multiple sclerosis

Metabolic Brain Disease(2021)10.1007/s11011-020-00652-w

N/A

0DataRank · unranked

15 citations

Iván Parra‐Izquierdo, András Gruber, Joseph J. Shatzel, Peter Pham, Larry S. Sherman +3 more

Pharmacological targeting of coagulation factor XI attenuates experimental autoimmune encephalomyelitis in mice

Metabolic Brain Disease(2023)10.1007/s11011-023-01251-1

N/A

0DataRank · unranked

12 citations

Meghan E. Fallon, E. Oseas, Laura D. Healy, Erik I. Tucker, David Gailani +5 more

Cytoprotective E-WE thrombin reduces disease severity in a murine model of relapsing-remitting multiple sclerosis

American Journal of Physiology-Cell Physiology(2023)10.1152/ajpcell.00377.2023

N/A

0DataRank · unranked

1 citations

Weiping Su, Peter Pham, Kelley R. Jordan, Tia C. L. Kohs, Erik I. Tucker +3 more

E-WE thrombin, a protein C activator, reduces disease severity and spinal cord inflammation in relapsing-remitting murine experimental autoimmune encephalomyelitis

Research Square(2023)10.21203/rs.3.rs-2802415/v1

N/A

0DataRank · unranked

0 citations

Weiping Su, Peter Pham, Kelley R. Jordan, Tia C. L. Kohs, Erik I. Tucker +3 more

Safety and tolerability of the protein C activator AB002 in end-stage renal disease patients on hemodialysis: a randomized phase 2 trial

Communications Medicine(2024)10.1038/s43856-024-00575-y

N/A

0DataRank · unranked

0 citations

Christina U. Lorentz, Brandon D. Markway, Michael Wallisch, Thomas Marbury, Enrico Di +4 more